Elevance Health (ELV) Invested Capital (2009 - 2026)

Elevance Health (ELV) has 18 years of Invested Capital data on file, last reported at $75.0 billion in Q1 2026.

• Invested Capital for Q1 2026 came in at $75.0 billion, up 3.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $75.0 billion (up 3.69% YoY), and the FY2025 annual result was $75.8 billion, up 4.82% from the prior year.
• Invested Capital retreated to $75.0 billion in Q1 2026 per ELV's latest filing, from $75.8 billion in the prior quarter.
• Over five years, Invested Capital peaked at $75.8 billion in Q4 2025 and troughed at $35.9 billion in Q2 2022.
• A 5-year average of $58.0 billion and a median of $63.1 billion in 2023 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2024 and 2025: Invested Capital slumped 30.7% in 2024, then jumped 77.61% in 2025.
• A 5-year view of Invested Capital shows it stood at $60.2 billion in 2022, then gained by 6.85% to $64.3 billion in 2023, then climbed by 12.43% to $72.3 billion in 2024, then increased by 4.82% to $75.8 billion in 2025, then declined by 1.0% to $75.0 billion in 2026.
• Business Quant data shows ELV's Invested Capital at $75.0 billion in Q1 2026, $75.8 billion in Q4 2025, and $44.1 billion in Q3 2025.